A study published in Nature Microbiology now shows for the first time that Candida auris uses a CO₂-based metabolic strategy to survive in the nutrient-poor conditions of the skin and to better tolerate antifungal therapies – especially amphotericin B (AMB).24. Dezember 2025
News Why Data Scarcity and Synthetic Over-Reliance Threaten Healthcare LLM RevolutionHealthradar4. Dezember 2025 Durga Chavali, MHA, Health Care IT Client Advisor Data, AI Strategist, Scholar & Advocate Large Language Models (LLMs) are rapidly…
News NVIDIA, Sheba, and Mount Sinai Partner to Decode 98% of Human Genome with LLMHealthradar18. November 2025 From left to right, first row: Michael Kagan, CTO, NVIDIA; Professor Yitshak Kreiss, Director General Sheba Medical Center; Dr. Alexander…
